Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Insulin Resistance & Diabetes

Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice

L. M. McShane; N. Irwin; D. O'Flynn; Z. J. Franklin; C. M. Hewage; F. P. O'Harte Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice J Endocrinol
Insulin Resistance & Diabetes

Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease

W. P. Martin; Y. H. D. Chuah; M. Abdelaal; A. Pedersen; D. Malmodin; S. Abrahamsson; M. Hutter; C. Godson; E. P. Brennan; L. Fändriks; C. W. le Roux; N. G. Docherty Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease Front Endocrinol (Lausanne)
Chronic Kidney Disease Insulin Resistance & Diabetes

Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice

F. C. McGillicuddy; C. M. Reynolds; O. Finucane; E. Coleman; K. A. Harford; C. Grant; D. Sergi; L. M. Williams; K. H. Mills; H. M. Roche Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice Am J Physiol Endocrinol Metab
Insulin Resistance & Diabetes

Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes

N. Irwin; P. Frizelle; I. A. Montgomery; R. C. Moffett; F. P. M. O'Harte; P. R. Flatt Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes Diabetologia
Insulin Resistance & Diabetes

A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling

N. P. Healy; A. M. Kirwan; M. A. McArdle; K. Holohan; A. B. Nongonierma; D. Keane; S. Kelly; L. Celkova; C. L. Lyons; F. C. McGillicuddy; O. M. Finucane; B. A. Murray; P. M. Kelly; L. Brennan; R. J. FitzGerald; H. M. Roche A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling Mol Nutr Food Res
Insulin Resistance & Diabetes

Endurance exercise training programs intestinal lipid metabolism in a rat model of obesity and type 2 diabetes

Y. H. Hung; M. A. Linden; A. Gordon; R. S. Rector; K. K. Buhman Endurance exercise training programs intestinal lipid metabolism in a rat model of obesity and type 2 diabetes Physiol Rep
Insulin Resistance & Diabetes

Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR

M. K. Hankir; T. Langseder; E. E. Bankoglu; Y. Ghoreishi; U. Dischinger; M. Kurlbaum; M. Kroiss; C. Otto; C. W. le Roux; T. Arora; F. Seyfried; N. Schlegel Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR iScience
Insulin Resistance & Diabetes

Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities

G. V. Graham; J. M. Conlon; Y. H. Abdel-Wahab; P. R. Flatt Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities Eur J Pharmacol
Insulin Resistance & Diabetes

A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice

C. Gaudel; A. B. Nongonierma; S. Maher; S. Flynn; M. Krause; B. A. Murray; P. M. Kelly; A. W. Baird; R. J. FitzGerald; P. Newsholme A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice J Nutr
Insulin Resistance & Diabetes

Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity

O. M. Finucane; C. L. Lyons; A. M. Murphy; C. M. Reynolds; R. Klinger; N. P. Healy; A. A. Cooke; R. C. Coll; L. McAllan; K. N. Nilaweera; M. E. O'Reilly; A. C. Tierney; M. J. Morine; J. F. Alcala-Diaz; J. Lopez-Miranda; D. P. O'Connor; L. A. O'Neill; F. C Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity Diabetes
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page27 Page28 Page29 Next →

Search for:

Recent Posts

Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update
ECO2023 Teaching Workshops – Registration Open!

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI